Dr. Uri Ladabaum serves as director of the Gastrointestinal Cancer Prevention Program and heads the Clinical Service of the Division of Gastroenterology and Hepatology at Stanford University School of Medicine. Dr. Ladabaum received his medical degree from the University of California, San Francisco, completed his residency and chief residency in internal medicine at Stanford University Hospital, and fellowship in gastroenterology at the University of Michigan, where he also obtained a M.S. degree in clinical research design and statistical analysis. He returned to the Bay Area in 1999 as a faculty member at the University of California, San Francisco, and joined the Stanford faculty in 2009.
Dr. Ladabaum's research focus is colorectal cancer risk management and prevention, including screening, risk stratification, and management of average-risk as well as high-risk populations, including persons with Lynch syndrome. His clinical efforts include providing consultation and screening and surveillance endoscopic services for average risk and high-risk persons, and caring for patients and families with suspected or established inherited cancer predisposition syndromes, including Lynch syndrome and polyposis syndromes. In addition, Dr. Ladabaum provides general gastroenterology consultation and endoscopic services.
Dr. Ladabaum's research program spans a range of methods and approaches including epidemiological studies, observational and interventional clinical studies, systematic reviews, decision analyses and health economic evaluations. Current efforts include exploring colorectal cancer screening tailored to risk, and enhancing the uptake of genetic testing and preventive interventions.